Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Clinicians(Electronic Edition) ›› 2023, Vol. 17 ›› Issue (06): 744-748. doi: 10.3877/cma.j.issn.1674-0785.2023.06.020

• Review • Previous Articles     Next Articles

Hydrogen for treatment of myocardial ischemia-reperfusion injury: mechanism and prospect

Minjie Zhang, Xiaoshan Zhang, Shasha Duan, Yilu Shi, Jie Zhao, Tianhao Bai, Yaxi Wang()   

  1. Department of Pediatrics of Xuzhou Central Hospital, Xuzhou 221009, China
    Department of Ultrasound, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China
  • Received:2022-05-20 Online:2023-06-15 Published:2023-08-09
  • Contact: Yaxi Wang

Abstract:

Myocardial ischemia-reperfusion injury (MIRI) is one of the key causes of myocardial injury, secondary to cardiovascular diseases, which is mostly present in coronary heart disease and during the perioperative period of cardiac surgery. MIRI elicits oxidative stress, inflammatory activity, and cell apoptosis, with a high incidence and mortality rate. The current treatments for MIRI include medicines and physical therapy, but with unsatisfactory effects. As a small molecule non-toxic reducing gas, hydrogen has a clear protective effect against cell ischemia-reperfusion, and has therefore become a promising treatment for MIRI. This paper reviews the mechanism of hydrogen for the treatment of MIRI and the preliminary prospect of its clinical application in the future.

Key words: Myocardial ischemia-reperfusion injury, Hydrogen, Oxidative stress, Inflammation, Apoptosis

京ICP 备07035254号-20
Copyright © Chinese Journal of Clinicians(Electronic Edition), All Rights Reserved.
Tel: 010-51322622 E-mail: zhlcyszz@cma.org.cn
Powered by Beijing Magtech Co. Ltd